<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Yang Lowry | Activity</title>
	<link>https://www.catswannabecats.com/members/daybar3/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/daybar3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Yang Lowry.</description>
	<lastBuildDate>Sat, 27 Jun 2026 18:56:28 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">c7ebcd3cd7353e69ddb86d79bfbee847</guid>
				<title>Yang Lowry posted an update: SS level worsening. Finally, these findings reaffirm the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/24481/</link>
				<pubDate>Sun, 08 Jun 2025 12:46:13 -0400</pubDate>

									<content:encoded><![CDATA[<p>SS level worsening. Finally, these findings reaffirm the fact that close clinical follow-up is important even among eyes that achieve substantial DRSS improvements with apparently quiescent disease.</p>
<p> To compare the outcomes of penetrating keratoplasty (PK) and deep anterior lamellar keratoplasty (DALK) for pediatric keratoconus.&hellip;<span class="activity-read-more" id="activity-read-more-24481"><a href="https://www.catswannabecats.com/activity/p/24481/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3eff7a0f19494958208ef085771ea356</guid>
				<title>Yang Lowry posted an update: The 3-year OS was 78.1% (95% CI 72.4-84.2%) for the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22464/</link>
				<pubDate>Sat, 07 Jun 2025 12:25:30 -0400</pubDate>

									<content:encoded><![CDATA[<p>The 3-year OS was 78.1% (95% CI 72.4-84.2%) for the high-risk group and 95% (95% CI 93.6-96.5%) in the low-risk group (HR 4.42, 95% CI 3.22-6.05; P&lt;0.001). This finding was also applied in the two external cohorts. Similarly, a nomogram that contained the same indices was developed and validated to predict for DFS.</p>
<p> Nomograms based on&hellip;<span class="activity-read-more" id="activity-read-more-22464"><a href="https://www.catswannabecats.com/activity/p/22464/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b27865012e47f96cbba9e6de1778fdf7</guid>
				<title>Yang Lowry posted an update: jor CES might also have been identified with a much more [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/21391/</link>
				<pubDate>Fri, 06 Jun 2025 13:36:59 -0400</pubDate>

									<content:encoded><![CDATA[<p>jor CES might also have been identified with a much more selective use of TTE.</p>
<p> Bioresorbable scaffolds (BRSs) is a relatively new approach in treating coronary artery stenosis. The initial results of the first commercially available scaffolds consisting of a backbone of poly-L-lactide raised safety concerns related to delayed resorption and&hellip;<span class="activity-read-more" id="activity-read-more-21391"><a href="https://www.catswannabecats.com/activity/p/21391/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a3f3375797fcfab2d4b5ae0116cfeff9</guid>
				<title>Yang Lowry posted an update: Research examining bone marrow adipose tissue (BMAT) has [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20259/</link>
				<pubDate>Thu, 05 Jun 2025 12:25:49 -0400</pubDate>

									<content:encoded><![CDATA[<p>Research examining bone marrow adipose tissue (BMAT) has rapidly expanded during the last two decades, leading to advances in knowledge on the role of BMAT in the pathogenesis of bone loss and endocrine disorders. Clinical imaging has played a crucial role for the in vivo assessment of BMAT, allowing non-invasive quantification and evaluation of&hellip;<span class="activity-read-more" id="activity-read-more-20259"><a href="https://www.catswannabecats.com/activity/p/20259/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9074fa79b37d51874213bfa1fc466db0</guid>
				<title>Yang Lowry posted an update: These changes determine not only the susceptibility to [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19045/</link>
				<pubDate>Wed, 04 Jun 2025 12:16:52 -0400</pubDate>

									<content:encoded><![CDATA[<p>These changes determine not only the susceptibility to infections, but also disease progression and clinical outcomes thereafter. Furthermore, the response to therapeutics and the immune response to vaccines are influenced by age-related changes within the immune system. Therefore, better understanding of the pathophysiology of aging and the&hellip;<span class="activity-read-more" id="activity-read-more-19045"><a href="https://www.catswannabecats.com/activity/p/19045/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5657be4ba036373184645b09c025a75d</guid>
				<title>Yang Lowry became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/7233/</link>
				<pubDate>Sat, 31 May 2025 18:30:28 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>